KLA Corporation just posted its sharpest single-day gain in months, yet the options market is now the most bullish it has been all year — and that combination demands attention.
The price move is striking. KLAC closed at $185.60 on September 4, up 7.3% on the day and 5.7% on the week. That reverses some of the 5% monthly loss and represents a meaningful reprieve for a stock that has spent most of 2026 under pressure. What makes the move interesting is where it came from: the broader semiconductor equipment group rallied in sympathy, with LRCX up 5.1% on the day and UCTT gaining 8.8%, suggesting a sector bid rather than a KLAC-specific catalyst. Still, KLAC held its own in a strong tape.
The options signal is the clearest change from last week. The put/call ratio dropped sharply to 1.45 — nearly three standard deviations below its 20-day average of 1.54, with a z-score of -2.88. That is the lowest defensive reading in the data going back to mid-July, and it is close to the 52-week low for the ratio at 1.26. Options traders have been rotating out of downside protection and into calls at the fastest pace in months. This stands in contrast to the previous note, published five days ago, which described a PCR essentially parked at its 20-day mean. That stasis has broken cleanly to the upside. The borrow market remains loose, reinforcing the picture: availability is effectively uncapped, cost to borrow sits at just 0.38%, and there is nothing in the lending market that points to any squeeze mechanics.
Short interest continues its steady retreat, which is the through-line connecting this week to the prior note. SI has fallen another 2.2% on the week to 18.4% of free float — down from a peak above 28.6 million shares in mid-August to roughly 24.2 million now. The direction of travel has been consistently lower for six weeks. The ORTEX short score has drifted slightly lower too, from 31.8 on August 24 to 30.5 now, placing KLAC in the 74th percentile on short score rank. That is elevated relative to the broader market, but the score's direction is falling, not rising — shorts are not adding conviction here.
The Street remains divided, and a recent UBS move adds a fresh wrinkle. Timothy Arcuri at UBS cut his target to $200 from $215 on September 1 while staying Neutral — a trim that sits just above the current price but well below the Street mean of $234. That move matters because it narrows the gap between the most cautious major analyst and where the stock is actually trading. Further out, bulls at Cantor Fitzgerald hold a $325 target and JP Morgan raised to $238 in late July after earnings. The post-earnings reaction from late July is worth noting: the stock fell 16.3% the day results were published before recovering much of that within five days. The bull case centres on KLAC's dominant position in process control and continued advanced-packaging demand from TSMC and Samsung. Bears flag valuation — even at $185.60, the P/E is 29.4x and EV/EBITDA is 24.5x — and the risk that China-related spending disappoints. EPS momentum factor scores are deeply negative, ranking in just the 2nd percentile over 90 days, meaning estimate cuts have been widespread and ongoing.
Insider activity from August adds context, though it does not change the near-term picture materially. CEO Richard Wallace sold 87,568 shares at roughly $199 on August 11, and CFO Bren Higgins sold 31,500 shares at $209 on August 12 — all under pre-arranged 10b5-1 plans, which reduces their signal value considerably. The net insider position over the past 90 days is -$53 million in aggregate value, spread across multiple executives. Planned sales from diversification programmes are a different beast from discretionary conviction sells, and there is no evidence here of executives stepping outside their trading plans.
With the next earnings date set for October 30, the question shaping the coming weeks is whether the options-market pivot toward calls reflects genuine fundamental re-rating or merely short-term relief buying into a bounce. The gap between the UBS $200 target and the Cantor $325 target is wide enough that the outcome of that earnings print will force a reckoning for at least one side of the debate.
See the live data behind this article on ORTEX.
Open KLAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
